Is the use of a nitroglycerin transdermal patch appropriate for treating low back pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nitroglycerin Patches Are Not Recommended for Low Back Pain

Nitroglycerin transdermal patches should not be used for the treatment of low back pain. This intervention lacks evidence-based support for this indication and is not mentioned in established clinical practice guidelines for low back pain management.

Evidence-Based Rationale

FDA-Approved Indications

The FDA label for nitroglycerin clearly states it is indicated only for acute relief or prophylaxis of angina pectoris due to coronary artery disease 1. There is no FDA approval for musculoskeletal pain conditions, including low back pain.

Absence from Clinical Practice Guidelines

The comprehensive 2007 American College of Physicians/American Pain Society guidelines for low back pain management 2 provide detailed recommendations for both pharmacologic and non-pharmacologic treatments but make no mention of nitroglycerin or nitrate therapy for this condition.

For acute low back pain, first-line pharmacologic options include 2:

  • Acetaminophen (slightly weaker analgesic but favorable safety profile)
  • NSAIDs (more effective for pain relief, with small but clinically relevant benefits)
  • Heat application for self-care

For chronic low back pain, recommended therapies include 2:

  • Exercise therapy
  • Spinal manipulation
  • Acupuncture
  • Massage therapy
  • Cognitive-behavioral therapy
  • NSAIDs or acetaminophen as needed

Limited and Irrelevant Research Evidence

While some research exists on transdermal nitroglycerin for other musculoskeletal conditions (shoulder tendinopathy 3, 4, lateral epicondylitis 5), these studies:

  • Do not address low back pain specifically
  • Show only short-to-mid-term benefits (up to 6 months) for tendinopathies
  • Are associated with common side effects including headaches and dermatitis 5

The mechanism of action proposed for tendinopathies (improved blood flow to tendons) does not translate to the pathophysiology of most low back pain, which is typically non-specific or related to mechanical factors rather than tendon pathology.

Clinical Pitfalls to Avoid

Do not extrapolate evidence from other conditions: The fact that nitroglycerin patches may help shoulder tendinopathy does not mean they will benefit low back pain—these are fundamentally different conditions with different underlying pathophysiology.

Recognize potential harms: Nitroglycerin can cause significant hypotension, particularly in upright posture 1, which could be dangerous for patients attempting to remain active (a key recommendation for low back pain management). Common side effects include severe headaches 1, which would compound rather than relieve patient suffering.

Avoid off-label use without evidence: Using nitroglycerin patches for low back pain represents off-label prescribing without supporting evidence, exposing patients to unnecessary risks and costs.

Appropriate Treatment Algorithm

Instead, follow this evidence-based approach 2:

First-line (all patients):

  • Reassurance and education about favorable natural history
  • Advice to remain active
  • Heat application for acute pain
  • Acetaminophen or NSAIDs (assess cardiovascular/GI risk factors before NSAIDs)

Second-line (if inadequate response after 2-4 weeks):

  • For acute pain: spinal manipulation
  • For chronic/subacute pain: exercise therapy, acupuncture, massage, yoga, or cognitive-behavioral therapy

Third-line (severe, disabling pain):

  • Consider skeletal muscle relaxants (short-term, acute pain)
  • Judicious use of opioids or tramadol (time-limited, with careful risk-benefit assessment)

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.